Æȷοì
Sun-Young Kong
Sun-Young Kong
ncc.re.krÀÇ À̸ÞÀÏ È®ÀεÊ
Á¦¸ñ
Àοë
Àοë
¿¬µµ
Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients
JH Shim, JW Park, JH Kim, M An, SY Kong, BH Nam, JI Choi, HB Kim, ...
Cancer science 99 (10), 2037-2044, 2008
2752008
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma
YT Tai, BY Chang, SY Kong, M Fulciniti, G Yang, Y Calle, Y Hu, J Lin, ...
Blood, The Journal of the American Society of Hematology 120 (9), 1877-1887, 2012
1982012
Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications
J Jakubikova, S Adamia, M Kost-Alimova, S Klippel, D Cervi, JF Daley, ...
Blood, The Journal of the American Society of Hematology 117 (17), 4409-4419, 2011
1802011
Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition
M Cea, A Cagnetta, M Fulciniti, YT Tai, T Hideshima, D Chauhan, ...
Blood, The Journal of the American Society of Hematology 120 (17), 3519-3529, 2012
1532012
Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability
SH Kang, KW Kang, KH Kim, B Kwon, SK Kim, HY Lee, SY Kong, ES Lee, ...
BMC cancer 8, 1-10, 2008
1502008
Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti‐myeloma activity in vitro and in vivo
K Kim, SY Kong, M Fulciniti, X Li, W Song, S Nahar, P Burger, ...
British journal of haematology 149 (4), 537-549, 2010
1462010
Incidence of diabetes after cancer development: a Korean national cohort study
Y Hwangbo, D Kang, M Kang, S Kim, EK Lee, YA Kim, YJ Chang, KS Choi, ...
JAMA oncology 4 (8), 1099-1105, 2018
1252018
Elevated red blood cell distribution width as a simple prognostic factor in patients with symptomatic multiple myeloma
H Lee, SY Kong, JY Sohn, H Shim, HS Youn, S Lee, HJ Kim, HS Eom
BioMed research international 2014, 2014
1122014
Association between vascular endothelial growth factor gene polymorphisms and survival in hepatocellular carcinoma patients
SY Kong, JW Park, JA Lee, JE Park, KW Park, EK Hong, CM Kim
Hepatology 46 (2), 446-455, 2007
1072007
Tumor-derived IL-18 induces PD-1 expression on immunosuppressive NK cells in triple-negative breast cancer
IH Park, HN Yang, KJ Lee, TS Kim, ES Lee, SY Jung, Y Kwon, SY Kong
Oncotarget 8 (20), 32722, 2017
922017
Prognostic implications of tumor-infiltrating lymphocytes in association with programmed death ligand 1 expression in early-stage breast cancer
IH Park, SY Kong, JY Ro, Y Kwon, JH Kang, HJ Mo, SY Jung, S Lee, ...
Clinical breast cancer 16 (1), 51-58, 2016
912016
Breast cancer diagnosis using a microfluidic multiplexed immunohistochemistry platform
MS Kim, T Kim, SY Kong, S Kwon, CY Bae, J Choi, CH Kim, ES Lee, ...
PloS one 5 (5), e10441, 2010
902010
Dual inhibition of canonical and noncanonical NF-¥êB pathways demonstrates significant antitumor activities in multiple myeloma
C Fabre, N Mimura, K Bobb, SY Kong, G Gorgun, D Cirstea, Y Hu, ...
Clinical Cancer Research 18 (17), 4669-4681, 2012
892012
Prognostic Implications of Multiplex Detection of KRAS Mutations in Cell-Free DNA from Patients with Pancreatic Ductal Adenocarcinoma
MK Kim, SM Woo, B Park, KA Yoon, YH Kim, J Joo, WJ Lee, SS Han, ...
Clinical chemistry 64 (4), 726-734, 2018
832018
Predicting tissue HER2 status using serum HER2 levels in patients with metastatic breast cancer
SY Kong, BH Nam, KS Lee, Y Kwon, ES Lee, MW Seong, DH Lee, J Ro
Clinical chemistry 52 (8), 1510-1515, 2006
712006
Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy
JY Kim, S Park, BH Nam, JW Roh, CH Lee, YH Kim, HJ Shin, SK Lee, ...
Journal of clinical oncology 27 (30), 5088-5093, 2009
692009
Serum HE4 level is an independent prognostic factor in epithelial ovarian cancer
SY Kong, MH Han, HJ Yoo, JH Hwang, MC Lim, SS Seo, CW Yoo, JH Kim, ...
Annals of surgical oncology 19, 1707-1712, 2012
682012
A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applications
J Jakubikova, D Cholujova, T Hideshima, P Gronesova, A Soltysova, ...
Oncotarget 7 (47), 77326, 2016
662016
Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated ¡¦
CR Oh, SY Kong, HS Im, HJ Kim, MK Kim, KA Yoon, EH Cho, JH Jang, ...
BMC cancer 19, 1-13, 2019
642019
CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients
SR Park, SY Kong, BH Nam, IJ Choi, CG Kim, JY Lee, SJ Cho, YW Kim, ...
British journal of cancer 104 (7), 1126-1134, 2011
592011
ÇöÀç ½Ã½ºÅÛÀÌ ÀÛµ¿µÇÁö ¾Ê½À´Ï´Ù. ³ªÁß¿¡ ´Ù½Ã ½ÃµµÇØ ÁÖ¼¼¿ä.
ÇмúÀÚ·á 1–20